{
    "references": [
        {
            "bibentry": "Benavides, J, Camelin, JC, Mitrani, N, Flamand, F, Uzan, A, Legrand, JJ, Gueremy, C, Le Fur, G. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission-II. Biochemical properties, Neuropharmacology, 1985, 24, 1085, 1092, PMID: 3001571",
            "process_entry": "True",
            "doi": "10.1016/0028-3908(85)90196-0",
            "pmid": "3001571",
            "xmlid": "ref1"
        },
        {
            "bibentry": "Bensimon, G, Lacomblez, L, Meininger, V. Group the AS, A controlled trial of riluzole in amyotrophic lateral sclerosis, N Engl J Med, 1994, 330, 585, 591, PMID: 8302340",
            "process_entry": "True",
            "doi": "10.1056/nejm199403033300901",
            "pmid": "8302340",
            "xmlid": "ref2"
        },
        {
            "bibentry": "Bissaro, M, Federico, S, Salmaso, V, Sturlese, M, Spalluto, G, Moro, S. Targeting protein kinase CK1δ with riluzole: could it be one of the possible missing bricks to interpret its effect in the treatment of ALS from a molecular point of view, ChemMedChem, 2018, 13, 2601, 2605, PMID: 30359484",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201800632",
            "pmid": "30359484",
            "xmlid": "ref3"
        },
        {
            "bibentry": "Dharmadasa, T, Kiernan, MC. Riluzole, disease stage and survival in ALS, Lancet Neurol, 2018, 17, 385, 386, PMID: 29525493",
            "process_entry": "True",
            "doi": "10.1016/s1474-4422(18)30091-7",
            "pmid": "29525493",
            "xmlid": "ref4"
        },
        {
            "bibentry": "Doble, A. The pharmacology and mechanism of action of riluzole, Neurology, 1996, 47, S233, 241, PMID: 8959995",
            "process_entry": "True",
            "doi": "10.1212/wnl.47.6_suppl_4.233s",
            "pmid": "8959995",
            "xmlid": "ref5"
        },
        {
            "bibentry": "Domino, EF, Unna, KR, Kerwin, J. Pharmacological properties of benzazoles. I. Relationship between structure and paralyzing action, J Pharmacol Exp Ther, 105, 486, 497",
            "process_entry": "True",
            "xmlid": "ref6"
        },
        {
            "bibentry": "Fumagalli, E, Bigini, P, Barbera, S, De Paola, M, Mennini, T. Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease, Exp Neurol, 2006, 198, 114, 128, PMID: 16386734",
            "process_entry": "True",
            "doi": "10.1016/j.expneurol.2005.11.010",
            "pmid": "16386734",
            "xmlid": "ref7"
        },
        {
            "bibentry": "Katz, JS, Woolley, SC. Amyotrophic Lateral Sclerosis, Physician's Field Guide to Neuropsychology, 2019, Springer New York: New York, NY",
            "process_entry": "True",
            "xmlid": "ref8"
        },
        {
            "bibentry": "Koek, W, Woods, JH. 2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys, Neuropharmacology, 1988, 27, 771, 775, PMID: 2843787",
            "process_entry": "True",
            "doi": "10.1016/0028-3908(88)90089-5",
            "pmid": "2843787",
            "xmlid": "ref9"
        },
        {
            "bibentry": "Nonaka, T, Suzuki, G, Tanaka, Y, Kametani, F, Hirai, S, Okado, H, Miyashita, T, Saitoe, M, Akiyama, H, Masai, H. Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1δ triggers mislocalization and accumulation of TDP-43, J Biol Chem, 2016, 291, 5473, 5483, PMID: 26769969",
            "process_entry": "True",
            "doi": "10.1074/jbc.M115.695379",
            "pmid": "26769969",
            "pmcid": "PMC4786690",
            "xmlid": "ref10"
        },
        {
            "bibentry": "Rosenblum, LT, Trotti, D. EAAT2 and the molecular signature of amyotrophic lateral sclerosis, In advances in neurobiology, 2017, 16, Springer, Cham, 117, 136",
            "process_entry": "True",
            "xmlid": "ref11"
        },
        {
            "bibentry": "Salado, IG, Redondo, M, Bello, ML, Perez, C, Liachko, NF, Kraemer, BC, Miguel, L, Lecourtois, M, Gil, C, Martinez, A. Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis, J Med Chem, 2014, 57, 2755, 2772, PMID: 24592867",
            "process_entry": "True",
            "doi": "10.1021/jm500065f",
            "pmid": "24592867",
            "pmcid": "PMC3969104",
            "xmlid": "ref12"
        }
    ],
    "localid": "MED-31397342",
    "doi": "10.4103/1673-5374.262578",
    "pmid": "10.4103/1673-5374.262578",
    "pmcid": "31397342",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31397342/fullTextXML",
    "reference_pointers": []
}